Hutch News

When on-target misses the mark: Lessons from HIV immunogens

When on-target misses the mark: Lessons from HIV immunogens

From the McGuire Lab, Vaccine and Infectious Disease Division
Science SpotlightJanuary 14, 2026
Test of a new 'germline-targeting' HIV vaccine prepares to launch

Test of a new 'germline-targeting' HIV vaccine prepares to launch

Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Hutch NewsMay 19, 2022
All immunogens are not created equal

All immunogens are not created equal

From the Stamatatos lab, Vaccine and Infectious Disease Division
Science SpotlightNovember 16, 2020
Antibodies from infected patients are a template for a SARS-CoV-2 vaccine

Antibodies from infected patients are a template for a SARS-CoV-2 vaccine

From the McGuire, Pancera, and Stamatatos labs, Vaccine and Infectious Disease Division
Science SpotlightAugust 17, 2020
Multi-step HIV-1 vaccines

Multi-step HIV-1 vaccines

From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Science SpotlightJanuary 20, 2020
Creating antibodies with antibodies

Creating antibodies with antibodies

From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Science SpotlightSeptember 16, 2019
Modified HIV immunogens engage neutralizing antibody precursors

Modified HIV immunogens engage neutralizing antibody precursors

From the Stamatatos lab, Vaccine and Infectious Disease Division
Science SpotlightJanuary 21, 2019
Wild-type vs. modification: which is better?

Wild-type vs. modification: which is better?

From Stamatatos Laboratory, Vaccine and Infectious Disease Division
Science SpotlightAugust 20, 2018